Document is current
Any future updates will be listed below
-
Authors
Schmidt, Amand F. http://orcid.org/0000-0003-1327-0424
Finan, Chris http://orcid.org/0000-0002-3319-1937
Gordillo-Marañón, Maria http://orcid.org/0000-0003-2993-6577
Asselbergs, Folkert W.
Freitag, Daniel F. http://orcid.org/0000-0003-0857-8950
Patel, Riyaz S.
Tyl, Benoît http://orcid.org/0000-0001-5297-8412
Chopade, Sandesh
Faraway, Rupert
Zwierzyna, Magdalena http://orcid.org/0000-0002-7445-6030
Hingorani, Aroon D. http://orcid.org/0000-0001-8365-0081
-
License Information
Text and Data Mining valid from 2020-06-26
Version of Record valid from 2020-06-26
-
More Information
Article History
Received: 16 October 2019
Accepted: 2 June 2020
First Online: 26 June 2020
Competing interests
: DFF is a full-time employee of Bayer AG, Germany. BT is a full-time employee of Servier. RSP has received honoraria from Sanofi, Bayer and Amgen. MZ is a full-time employee of GSK. AFS and FWA have received Servier funding for unrelated work. MZ conducted this research as an employee of BenevolentAI. Since completing the work MZ is now a full-time employee of GlaxoSmithKline. None of the remaining authors have a competing interest to declare.
